256 related articles for article (PubMed ID: 22850410)
1. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
Gui T; Cao D; Shen K; Yang J; Zhang Y; Yu Q; Wan X; Xiang Y; Xiao Y; Guo L
Gynecol Oncol; 2012 Nov; 127(2):384-9. PubMed ID: 22850410
[TBL] [Abstract][Full Text] [Related]
2. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
[TBL] [Abstract][Full Text] [Related]
3. Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.
Akman L; Ertas IE; Gokcu M; Terek MC; Sanci M; Sanli UA; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):290-4. PubMed ID: 27072253
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases.
Guo Y; Wang J; Li Y; Wang Y
Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature.
Xiao H; Li B; Zuo J; Feng X; Li X; Zhang R; Wu L
Gynecol Endocrinol; 2013 Mar; 29(3):192-5. PubMed ID: 23173550
[TBL] [Abstract][Full Text] [Related]
7. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
8. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
[TBL] [Abstract][Full Text] [Related]
9. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
Bhat RA; Lim YK; Chia YN; Yam KL
J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
Wang G; Zhang R; Li C; Chen A
J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
[TBL] [Abstract][Full Text] [Related]
11. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
13. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
14. Sertoli-Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study.
Weng CS; Chen MY; Wang TY; Tsai HW; Hung YC; Yu KJ; Chiang YC; Lin H; Lu CH; Chou HH
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):66-70. PubMed ID: 23548221
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel GM; Buza N; Pal L
Eur J Gynaecol Oncol; 2017; 38(2):214-220. PubMed ID: 29953783
[TBL] [Abstract][Full Text] [Related]
17. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 11 cases of ovarian Setoli-Leydig cell tumor].
Li B; Wu LY; Zhang WH; Li L; Ma SK; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):334-7. PubMed ID: 15196418
[TBL] [Abstract][Full Text] [Related]
19. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
Zhang HY; Zhu JE; Huang W; Zhu J
Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
